Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL846974 | 0.81 | FFAR3 (0.46) | LMNACYP2C9 | |
| SCHEMBL12634644 | 0.79 | PKM (0.33) | — | |
| SCHEMBL847157 | 0.79 | NR1I2 (0.31) | — | |
| SCHEMBL12688265 | 0.79 | — | — | |
| SCHEMBL847017 | 0.76 | DRD2 (0.33) | — | |
| SCHEMBL663921 | 0.76 | MEN1 (0.33) | — | |
| SCHEMBL17688059 | 0.74 | ATM (0.31) | — | |
| SCHEMBL1970312 | 0.74 | KCNA4 (0.39) | — | |
| SCHEMBL7996386 | 0.74 | — | — | |
| SCHEMBL19860154 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9987369-B2 | Vitamin functionalized gel-forming block copolymers for biomedical applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-06-05 | — | — | US | disclosed |
| US-20180117162-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-05-03 | — | — | US | disclosed |
| US-20170202217-A1 | ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF | NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) | 2017-07-20 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-9637592-B2 | Vitamin functionalized gel-forming block copolymers for biomedical applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-05-02 | — | — | US | disclosed |
| US-20170114183-A1 | METHODS OF FORMING BLOCK POLYMERS FOR DIRECTED SELF-ASSEMBLY | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-04-27 | — | — | US | disclosed |
| US-20170051105-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-02-23 | — | — | US | disclosed |
| US-9562127-B2 | Methods of forming block polymers for directed self-assembly | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-02-07 | — | — | US | disclosed |
| US-9511146-B2 | Vitamin functionalized gel-forming block copolymers for biomedical applications | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2016-12-06 | — | — | US | disclosed |
| US-9388275-B2 | Method of ring-opening polymerization, and related compositions and articles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2016-07-12 | — | — | US | disclosed |
| US-20110182996-A1 | SURFACE MODIFIED NANOPARTICLES, METHODS OF THEIR PREPARATION, AND USES THEREOF FOR GENE AND DRUG DELIVERY | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-07-28 | — | — | US | disclosed |
| US-20110182996-A1 | SURFACE MODIFIED NANOPARTICLES, METHODS OF THEIR PREPARATION, AND USES THEREOF FOR GENE AND DRUG DELIVERY | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-07-28 | — | — | US | disclosed |
| US-20110054064-A1 | Hydrogel Compositions and Methods of Preparation Thereof | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110009571-A1 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS | ALCON RESEARCH, LLC | 2011-01-13 | — | — | US | disclosed |
| US-20100317838-A1 | CYCLIC CARBONYL MONOMERS FUNCTIONALIZED WITH CARBOHYDRATES, POLYMERS DERIVED THEREFROM, AND METHODS OF PREPARATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-16 | — | — | US | disclosed |
| US-20100311917-A1 | METHODS FOR MAKING MULTI-BRANCHED POLYMERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2010-12-09 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305300-A1 | Method of Ring-Opening Polymerization, and Related Compositions and Articles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-6228979-B1 | REACTING PRIMARY AMINE OR ALKYLENIMINE WITH AN ALKYLENE CARBONATE BEARING A PENDANT KETONE OR ESTER MOIETY WITH QUICK REACTION TIMES TO YIELD CORRESPONDING DECYCLIZED HYDROXYALKYLCARBAMATE COMPOUND USEFUL AS REACTIVE DILUENT | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-05-08 | — | — | US | disclosed |
| US-6020499-A | Cyclic carbonates and their reactions with amines | E. I. DU PONT NEMOURS AND COMPANY (US) | 2000-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202217-A1 | ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF | WASF2, HASPIN, MRPL21 | LMNA 2751/4885CYP2C9 2548/4885 |
| US-20170051105-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | VDR, PROC, CYP24A1 | LMNA 2391/4885CYP2C9 463/4885 |
| US-20110182996-A1 | SURFACE MODIFIED NANOPARTICLES, METHODS OF THEIR PREPARATION, AND USES THEREOF FOR GENE AND DRUG DELIVERY | ABCB7, CD63, ITGB3 | LMNA 1076/4885CYP2C9 1127/4885 |
| US-20100317838-A1 | CYCLIC CARBONYL MONOMERS FUNCTIONALIZED WITH CARBOHYDRATES, POLYMERS DERIVED THEREFROM, AND METHODS OF PREPARATION THEREOF | FUT6, FUT5, WASF2 | LMNA 1176/4885CYP2C9 3517/4885 |
| US-20180117162-A1 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | VDR, PROC, CYP24A1 | LMNA 2122/4885CYP2C9 796/4885 |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | ACMSD, CARM1, PBRM1 | LMNA 892/4885CYP2C9 2140/4885 |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | PFAS, PAM, PCNA | LMNA 1875/4885CYP2C9 3399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.